Información de ICON PLC, dividendo de ICON PLC, actividades de los accionistas y más

Más Datos de ICON PLC Compañía

ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

Información de ICON PLC



Símbolo de cotizaciónICLR

Nombre de la empresaICON PLC

Fecha de salida a bolsaMay 15, 1998

Director ejecutivoBalfe (Barry Edward)

Número de empleados41900

Tipo de seguridadOrdinary Share

Fin del año fiscalMay 15

DirecciónSouth County Business Park

CiudadDUBLIN

Bolsa de valoresNASDAQ OMX - NASDAQ BASIC

PaísIreland

Código postal- -

Teléfono35312912000

Sitio Webhttps://www.iconplc.com/

Símbolo de cotizaciónICLR

Fecha de salida a bolsaMay 15, 1998

Director ejecutivoBalfe (Barry Edward)

Ejecutivos de ICON PLC



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Ciaran Murray

Non-Executive Independent Chairman of the Board

20.00K

+3.28%

Dr. John Climax

Independent Director

--

Mr. Diarmaid Cunningham

Chief Administrative Officer, General Counsel, Company Secretary

--

Dr. Stephen (Steve) Cutler, Ph.D.

Non-Executive Director

--

Mr. Eugene Mccague

Independent Director

--

Ms. Julie O'Neill

Independent Director

--

Mr. Ronan Murphy

Lead Independent Director

--

Dr. Linda S. Grais, M.D., J.D.

Independent Director

--

Ms. Anne C. Whitaker

Independent Director

--

Mr. Barry Edward Balfe

Chief Executive Officer, Chief Operating Officer

--

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Ciaran Murray

Non-Executive Independent Chairman of the Board

20.00K

+3.28%

Dr. John Climax

Independent Director

--

Mr. Diarmaid Cunningham

Chief Administrative Officer, General Counsel, Company Secretary

--

Dr. Stephen (Steve) Cutler, Ph.D.

Non-Executive Director

--

Mr. Eugene Mccague

Independent Director

--

Ms. Julie O'Neill

Independent Director

--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de abr

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

La empresa aún no ha revelado los datos relevantes.

Por regiónUSD

Nombre

Ganancia

Proporción

Ireland

758.53M

37.13%

United States

647.28M

31.69%

Rest of Europe

402.44M

19.70%

Rest of the World

234.57M

11.48%

Por negocio

Por región

La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: jue., 7 de may

Accionistas

Tipos de accionistas

Accionistas

Proporción

Artisan Partners Limited Partnership

10.95%

Wellington Management Company, LLP

5.70%

Orbis Investment Management Ltd.

5.52%

Principal Global Investors (Equity)

4.34%

Invesco Advisers, Inc.

4.31%

Otro

69.18%

Accionistas

Proporción

Artisan Partners Limited Partnership

10.95%

Wellington Management Company, LLP

5.70%

Orbis Investment Management Ltd.

5.52%

Principal Global Investors (Equity)

4.34%

Invesco Advisers, Inc.

4.31%

Otro

69.18%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

48.76%

Investment Advisor/Hedge Fund

46.73%

Hedge Fund

7.18%

Research Firm

1.62%

Pension Fund

1.60%

Sovereign Wealth Fund

1.15%

Family Office

1.09%

Family Office

1.09%

Bank and Trust

1.09%

Participación institucional



Actualizado: dom., 5 de abr

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2026Q1

1395

83.08M

108.80%

-15.43M

2025Q4

1382

81.98M

107.36%

-15.69M

2025Q3

1350

79.42M

104.00%

-10.34M

2025Q2

1335

74.28M

95.51%

-11.33M

2025Q1

1362

81.04M

101.97%

-5.18M

2024Q4

1334

80.88M

97.97%

-5.29M

2024Q3

1290

83.28M

100.86%

-2.02M

2024Q2

1273

83.12M

100.37%

-2.47M

2024Q1

1254

83.08M

100.49%

-3.81M

2023Q4

1237

84.94M

102.98%

-3.00M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

Artisan Partners Limited Partnership

8.36M

10.95%

+1.49M

+21.64%

Feb 27, 2026

Wellington Management Company, LLP

4.35M

5.7%

-286.39K

-6.18%

Dec 31, 2025

Orbis Investment Management Ltd.

4.21M

5.52%

+75.84K

+1.83%

Dec 31, 2025

Principal Global Investors (Equity)

3.00M

3.93%

-275.76K

-8.41%

Dec 31, 2025

Invesco Advisers, Inc.

3.29M

4.31%

+443.92K

+15.58%

Dec 31, 2025

Harris Associates L.P.

2.51M

3.29%

+167.61K

+7.15%

Dec 31, 2025

Fidelity Management & Research Company LLC

2.39M

3.13%

+802.19K

+50.64%

Dec 31, 2025

Templeton Investment Counsel, L.L.C.

2.27M

2.97%

+188.41K

+9.07%

Dec 31, 2025

MFS Investment Management

2.20M

2.88%

-986.98K

-31.00%

Dec 31, 2025

ETFs relacionados



Actualizado: sáb., 6 de dic

Nombre

Proporción

iShares MSCI Ireland ETF

4.48%

Harbor Health Care ETF

3.34%

Polen Capital International Growth ETF

3.14%

VanEck Biotech ETF

3.13%

Motley Fool Global Opportunities ETF

2.94%

Tema Durable Quality ETF

2.07%

Invesco Bloomberg Pricing Power ETF

1.89%

Running Oak Efficient Growth ETF

1.83%

FPA Global Equity ETF

1.81%

Brandes US Value ETF

1.77%

iShares MSCI Ireland ETF

Proporción4.48%

Harbor Health Care ETF

Proporción3.34%

Polen Capital International Growth ETF

Proporción3.14%

VanEck Biotech ETF

Proporción3.13%

Motley Fool Global Opportunities ETF

Proporción2.94%

Tema Durable Quality ETF

Proporción2.07%

Invesco Bloomberg Pricing Power ETF

Proporción1.89%

Running Oak Efficient Growth ETF

Proporción1.83%

FPA Global Equity ETF

Proporción1.81%

Brandes US Value ETF

Proporción1.77%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos